No abstract

This publication presents the results of clinical application of the system of non-extensible compression adjustable bandage in the treatment of upper and lower limb lymphedema in 14 patients over a period of 2 to 34 months. An adjustable non-extensible compression bandage was used as monotherapy for stage I–IIa congenital limb lymphedema in 5 out-of-hospital patients. Progression of edema was not registered in any case during the follow-up period of up to 34 months. In 7 patients with stage IIB-III limb lymphedema, as well as in a 41-year-old patient with a diagnosis Of: Congenital abnormality development of the lymphatic system, Neurofibromatosis type 1, a disease Recklinghausen adjustable non-stretchable compression the product is used in combination with medical compression hosiery 1–2 compression class international standard RAL-Gz 387 from early (first show after 9–11 days after surgery) and continuing in the distant (period of use up to 22 months) postoperative periods. The return of edema (more than 1 cm when measuring the circumference) of the remodeled limb was observed in 3 patients after 4 months of follow-up. At 22 months (the maximum observation period), 2 patients showed an increase in the circumference of the operated limb to 2.5 cm. The system of non-extensible compression adjustable bandage in real clinical practice shows high efficiency in achieving edema reduction in stage I lymphedema of the extremities for at least 24 months. The use of adaptive compression banding system for the prevention of edema regression after surgical interventions for stage III limb lymphedema was reliably effective for 12 months.

No abstract

No abstract

No abstract